Healthcare & Life Sciences
Nuvectis Pharma
Germany
series-c-plus
series-c-plus
Stage
1
Investors
About
Nuvectis Pharma is developing immune-oncology drugs that target the tumor microenvironment to enhance cancer treatment effectiveness.
Explore Nuvectis Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.